Skye Bioscience, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Nature of Operations, Business Activities and Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Related Party Matters (Detail Textuals)

v3.19.2

Related Party Matters (Detail Textuals) - USD ($)			1 Months Ended	3 Months Ended		6 Months Ended
Related Party Matters (Detail Textuals) - USD ($)	Feb. 06, 2018	Apr. 01, 2017	Feb. 28, 2018	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Related Party Transaction [Line Items]
Monthly fee		$ 10,000				$ 20,000
Total expense incurred under agreement					$ 0		$ 220,000
Independent contractor agreement \| Emerald Health Sciences Inc
Related Party Transaction [Line Items]
Total expense incurred under agreement				$ 150,000	150,000	$ 300,000	250,000
Initial term of agreement						10 years
Percentage of accrued interest on outstanding balance						12.00%
Separation and release agreement \| K2C, Inc.
Related Party Transaction [Line Items]
Lump sum payment in agreement			$ 180,000
Recognized additional stock based compensation expense of restricted stock and option awards						$ 112,270
Separation and release agreement \| K2C, Inc. \| Immediate vesting
Related Party Transaction [Line Items]
Number of restricted common stock vested			900,000
Separation and release agreement \| K2C, Inc. \| October 20, 2015
Related Party Transaction [Line Items]
Number of restricted common stock vested			325,000
Separation and release agreement \| K2C, Inc. \| November 21, 2014
Related Party Transaction [Line Items]
Number of restricted common stock vested			125,000
Consulting Agreement \| Emerald Health Sciences Inc
Related Party Transaction [Line Items]
Total expense incurred under agreement					$ 15,000		$ 30,000
Initial term of agreement	1 year
Annual fee	$ 60,000
Period of discretionary annual bonus payable to contractor after each fiscal year end	120 days

- Definition

Represents amount of annual fee.

+ References

No definition available.

+ Details

Name:	embi_AnnualFeeForAgreement
Namespace Prefix:	embi_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the initial term of agreement.

+ References

No definition available.

+ Details

Name:	embi_InitialTermOfAgreement
Namespace Prefix:	embi_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount related to lump sum payment in the agreement.

+ References

No definition available.

+ Details

Name:	embi_LumpSumPaymentInAgreement
Namespace Prefix:	embi_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Represents amount of monthly fee.

+ References

No definition available.

+ Details

Name:	embi_MonthlyFee
Namespace Prefix:	embi_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents percentage of interest on accrued the outstanding balance

+ References

No definition available.

+ Details

Name:	embi_PercentageOfAccruedInterestOnOutstandingBalance
Namespace Prefix:	embi_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Period of discretionary annual bonus payable to contractor after each fiscal year end.

+ References

No definition available.

+ Details

Name:	embi_PeriodOfDiscretionaryAnnualBonusPayableToContractorAfterEachFiscalYearEnd
Namespace Prefix:	embi_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents total expense incurred under the agreement.

+ References

No definition available.

+ Details

Name:	embi_TotalExpenseIncurredUnderAgreement
Namespace Prefix:	embi_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

+ Details

Name:	us-gaap_AllocatedShareBasedCompensationExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_RelatedPartyTransactionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=embi_IndependentContractorAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=embi_EmeraldHealthSciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=embi_SeparationAndReleaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=embi_K2CIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=embi_ConsultingAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: